ABSA International
ABSA International

Resources with keywords: covid-19



COVID-19 Data Review: Update on COVID-19–Related Mortality (Website, Regulatory)
CDC

COVID-19 Data Reviews provide timely updates and share preliminary results of analyses that can improve the understanding of the pandemic and inform further scientific inquiry.

BU researchers create hybrid COVID virus, causing friction with the government (Website, News)
Boston.com
17 October 2022

Recent research conducted by Boston University scientists involving a hybrid version of the COVID-19 virus is causing a stir in the scientific community. The work seemingly caught one of the research’s primary funding sources off guard, and has generated headlines alleging that the researchers created a more lethal version of COVID-19.

Stay Up to Date with COVID-19 Vaccines Including Boosters (Website, Regulatory)
CDC
Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (Website, Regulatory)
FDA
12 October 2022
The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis (Website)
Cambridge University Press
6 December 2022

Marra AR, Kobayashi T, Suzuki H, et al.

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022 (Website, Publication, Regulatory)
CDC/MMWR
2 December 2022

Shah MM, Joyce B, Plumb ID, et al.

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 (Website, Publication, Regulatory)
CDC/MMWR
2 December 2022

Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al.

keywords: covid-19, testing
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022 (Website, Regulatory)
CDC/MMWR
4 November 2022

Hause AM, Marquez P, Zhang B, et al.
Early safety findings from v-safe and the Vaccine Adverse Event Reporting System for bivalent booster doses administered to persons aged ≥12 years during the first 7 weeks of vaccine availability are similar to those previously described for monovalent vaccine booster vaccines.

An Analysis of the Origins of the COVID-19 Pandemic (Document)
US Senate Committee on Health Education, Labor and Pensions, Minority Oversight Staff
1 October 2022

The objective of this report was to review publicly available, open-source information to examine the two prevailing theories of origin of the SARS-CoV-2 virus: a natural zoonotic outbreak or a research-related incident.

keywords: covid-19, origin
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages (Website, Publication)
Science: Translational Medicine
22 September 2022

Martínez-Colón GJ, Ratnasiri K, et al.
Authors state that the data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages.

Go to Top